Christopher Sweeney

Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

Jeffrey S. Hrkach, Daniel D. Von Hoff, Mir Mukkaram Ali et al. · Science Translational Medicine · 2012 · 1.1K citations

Pharmacy, Pharmaceutics, Pharmacology +17

A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy

Alan Sandler, Michael A. Gordon, Dinesh P. de Alwis et al. · Clinical Cancer Research · 2004 · 151 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

SPINK1 Protein Expression and Prostate Cancer Progression

Richard Flavin, Andreas Pettersson, Whitney K. Hendrickson et al. · Clinical Cancer Research · 2014 · 81 citations · Full text

Medicine, Oncology, Urology +17

A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors

E. Gabriela Chiorean, Christopher Sweeney, Hagop Youssoufian et al. · Cancer Chemotherapy and Pharmacology · 2014 · 61 citations

Pharmacy, Oncology, Immunotherapy +15

A Phase II Trial of Irinotecan, 5-Fluorouracil and Leucovorin Combined with Celecoxib and Glutamine as First-Line Therapy for Advanced Colorectal Cancer

Chong‐Xian Pan, Patrick J. Loehrer, David Seitz et al. · Oncology · 2005 · 34 citations

Medicine, Oncology, Pharmacology +15